Contralateral Occluded Carotid Defines Revascularization Strategy

A significative lesion to the carotid artery in addition to contralateral carotid occlusion is an obvious factor of high risk for a revascularization procedure. However, this might be true for surgery but not for carotid artery stenting according to this recent publication in JACC.

Carótida ocluida contralateral define la estrategia de revascularización

The presence of contralateral carotid occlusion has been established as high risk for patients undergoing carotid endarterectomy, even though recent observational studies have cast a shadow on this paradigm. 

The aim of this study was to determine the clinical impact of contralateral occlusion in contemporary patients receiving endarterectomy or carotid artery stenting.  

All patients from a national registry receiving carotid revascularization presenting contralateral occlusion were included. 

Primary end point was a combination of death, stroke and MI.


Read also: Solution for Type 1A Endoleaks After Abdominal Endoprosthesis.


Of 58423 patients undergoing carotid revascularization, 7.9% (n=4624) had contralateral occlusion. Among these, 68.9% (n=3185) received surgery and 31.1% (n=1439) carotid artery stenting. Nearly half of patients (45.4%) presented with symptomatic disease because of prior stroke of transient ischemic attack. 

After multiple adjustments of different variables, researchers observed that a history of contralateral occlusion was associated with 71% increased events risk after endarterectomy (p<0.001), vs. no increased risk with carotid artery stenting (OR 0.94; CI 95%, p=0.64).

Conclusion

Contralateral carotid occlusion is an important risk factor for patients undergoing endarterectomy but no for patients receiving carotid artery stenting. This factor should be taken into account when deciding for or against a revascularization strategy. 

Original Title: Clinical Impact of Contralateral Carotid Occlusion in Patients Undergoing Carotid Artery Revascularization.

Reference: Anna K Krawisz et al. J Am Coll Cardiol. 2021 Feb 23;77(7):835-844. doi: 10.1016/j.jacc.2020.12.032.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Is abdominal aortic aneurysm screening cost-effective in women?

Although ultrasound screening for abdominal aortic aneurysm (AAA) is a well-established strategy in men over 65 years of age, its value in women remains...

Aneurysm Sac Regression Predicts Better Clinical Outcomes After EVAR?

Aneurysm sac regression following endovascular abdominal aortic aneurysm repair (EVAR) has been proposed as a marker of favorable remodeling and effective aneurysm exclusion. However,...

SPYRAL Program: 3-Year Outcomes in Patients Treated with Renal Denervation

Hypertension is the leading modifiable risk factor for cardiovascular disease and remains a major global health challenge, affecting more than one billion adults worldwide.  Despite...

Drug-Eluting Stents in Peripheral Arterial Disease: When Should They Be Used?

Peripheral drug-eluting stents have transformed the treatment of peripheral arterial disease by reducing restenosis rates and the need for repeat interventions. However, the emergence...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

Is IVUS Always Necessary for Left Main Coronary Artery PCI?

Percutaneous coronary intervention (PCI) of the unprotected left main coronary artery is a highly complex procedure because of the large amount of myocardium at...

Dual-Prep Registry: Atherectomy and IVL for Severe Coronary Calcification

Severe coronary calcification remains one of the most challenging scenarios in percutaneous coronary intervention (PCI). Although rotational or orbital atherectomy and intravascular lithotripsy (IVL)...

Hemodynamic Outcomes of Edge-to-Edge Repair in Degenerative and Functional Mitral Regurgitation

Transcatheter edge-to-edge mitral valve repair (M-TEER) has become an established therapeutic option for mitral valve disease. Among the available techniques, M-TEER using the MitraClip...